KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index

Target's Q2 2026 earnings release is set for August 19, 2026; low importance is estimated as the date announcement itself typically has a market impact of less than 5%, scheduled.

The U.S. FDA set a PDUFA target action date for iberdomide on 2026-08-17; importance is Low as the setting of a PDUFA date is a procedural event with minor price impact.

Q2 2026 earnings release is scheduled for August 7, 2026; analysts forecast a significant increase in earnings due to higher oil prices and full integration of Hess assets. Market impact is estimated at Medium (5%) as earnings are a primary driver of stock volatility, scheduled.

Q2 2026 earnings release is scheduled.

Q3 2026 earnings release and conference call scheduled.

Q2 2026 earnings release is scheduled.

Second quarter 2026 earnings release scheduled; medium impact expected as a key financial update.

Comcast's Q2 2026 earnings release on July 30, 2026 scheduled. Medium importance is estimated as earnings reports often impact stock prices.

Bristol-Myers Squibb Q2 2026 earnings release on 2026-07-30 scheduled; importance is Low as the announcement of an earnings date typically has a <5% price impact.

Q3 2026 earnings release and conference call scheduled. Estimated > 10% impact as quarterly earnings are primary volatility drivers.

Q4 and full fiscal year 2026 earnings results scheduled; estimated 5% price impact based on historical earnings volatility, scheduled.

Q2 2026 earnings release is scheduled for July 28, 2026. Analysts forecast EPS of approximately $0.93. Low impact is anticipated as the event has not yet occurred scheduled.

Texas Instruments Q2 2026 earnings release on 2026-07-22. The company forecasted revenue between $5.0B and $5.4B and EPS between $1.77 and $2.05. High importance estimated due to typical earnings volatility scheduled

Q2 2026 earnings release on July 22, 2026 expected

Regions Financial is scheduled to announce its Q2 2026 financial results on July 17, 2026, before the market opens. Earnings releases typically cause significant volatility, justifying a Medium importance estimate. This is a scheduled event.

State Street Corporation is scheduled to announce its second-quarter 2026 financial results on July 16, 2026, before the market opens, with a conference call at 11:00 a.m. ET; high importance is estimated based on the potential for a price impact of 10% or more, scheduled.

Abbott's Q2 2026 earnings release is scheduled for July 16, 2026. Analysts forecast EPS of $1.28. Medium importance estimated as earnings typically drive >5% price movement expected.

Bank OZK's Q2 2026 earnings release, which frequently causes >5% price movement, is expected.

PepsiCo is scheduled to release its Q2 2026 financial results. Analysts' consensus forecast is for an EPS of approximately $2.22, scheduled. Medium importance is estimated as earnings releases typically impact stock prices by 5% or more.

MSC Industrial Direct's fiscal third quarter 2026 earnings release. Analysts forecast earnings of $1.25 per share, reflecting a year-over-year increase of 15.74%. High importance estimated due to potential for >10% price volatility, scheduled.

The ex-dividend date for an increased quarterly cash dividend of $0.55 per share, raised from $0.54. The dividend was announced on April 17, 2026, with the ex-date set for July 2, 2026 scheduled. Low importance as dividend increases are standard corporate actions.

Comcast declared a quarterly dividend of $0.33 per share. The ex-dividend date is July 1, 2026, with the payment date set for July 22, 2026.

NIKE, Inc. plans to release its fourth quarter fiscal 2026 financial results after the market closes on June 30, 2026, followed by a conference call with management. This release will cover the full fiscal year performance and provide future guidance. High importance is estimated as earnings releases typically cause significant price volatility, scheduled.

Ex-dividend date for the Q2 2026 dividend of $1.61 per share, payable on July 10, 2026 scheduled. Low impact estimated as it is a routine dividend.

The ex-dividend date (2026-06-30) for a regular quarterly dividend of $0.50 per share, declared on May 20, 2026, is scheduled. This event is estimated to have a price impact of at least 1% scheduled.

Darden Restaurants plans to release its fiscal 2026 fourth quarter and full year financial results before the market opens on June 25, 2026, scheduled. High importance is estimated as annual earnings reports typically result in significant price volatility exceeding 10%.

As a recurring major financial disclosure, this event has the potential for a significant market reaction; Q4 fiscal year 2026 earnings release is scheduled.

Investor Day 2026 in New York City to outline growth and diversification strategy with a focus on AI scheduled. Estimated > 1% impact as it provides long-term strategic clarity.

The ex-dividend date for a regular quarterly cash dividend of $1.70 per share on June 12, 2026. The dividend was declared on April 8, 2026, and is payable on July 1, 2026. Market impact is expected to be low as this is a routine corporate action, scheduled.

Quarterly cash dividend of $1.25 per share has an ex-dividend date of June 12, 2026. The dividend is scheduled to be paid on June 26, 2026.

Ex-dividend date for a quarterly cash dividend of $0.40 per share, announced on April 27, 2026, scheduled. A standard dividend announcement typically has a low price impact.

The ex-dividend date for the quarterly cash dividend of $0.525 per share is on June 12, 2026. The dividend is payable on June 29, 2026, with low impact expected from this regular distribution, scheduled.

Comcast's Annual General Meeting on June 10, 2026 scheduled. Low importance is estimated as AGMs typically result in minimal price movement.

Quarterly cash dividend of $1.30 per share, with an ex-dividend date of June 9, 2026 and a payment date of June 25, 2026.

Regions Financial is scheduled to participate in the Morgan Stanley U.S. Financials Conference on June 9, 2026. Conference participation usually has a minor impact on stock price, justifying a Low importance estimate. This is a scheduled event.

Quarterly dividend of $1.56 per share with an ex-dividend date of 2026-06-04 expected; low impact expected from routine dividend.

Quarterly dividend of $2.33 per share, ex-dividend date on 2026-06-04.

Ex-dividend date for the increased quarterly cash dividend of $0.92 per share, payable on June 25, 2026, scheduled for June 4, 2026. Estimated > 1% impact as the dividend amount is significant.

Management participated in the Baird 2026 Global Consumer, Technology and Services Conference, scheduled. Conference participation generally has a low price impact.

CME Group reported record May 2026 average daily volume (ADV) of 33.2 million contracts, a 15% increase year-over-year, driven by strong growth in interest rate and equity index products.

Announced on 2026-06-02 that Julie Knecht will be appointed as the new Chief Financial Officer, effective August 1, 2026, succeeding the retiring CFO Rafael Lizardi.

Comcast announced the pricing terms for its cash tender offer to purchase certain outstanding notes, part of a debt management strategy. The offer, which commenced May 27, 2026, expired on June 2, 2026.

Keybanc analysts maintained an Overweight rating and raised the price target on MSC Industrial shares to $129 from $117, citing cost-reduction initiatives and improving end-market demand, forecasted.

Comcast completed the divestiture of Sky Deutschland, with RTL Group confirming the closing of the acquisition on June 1, 2026. The deal had received unconditional approval from the European Commission on April 22, 2026.

The European Commission granted marketing authorization for IMDYLLTRA® (tarlatamab) on 2026-06-01 for the treatment of ES-SCLC; expected to have a medium market impact of approximately 5% due to expanded market access.

Stock price declined significantly following the launch of a competing equity index futures product by a rival exchange on June 1, 2026, and regulatory approval for competitors' perpetual bitcoin futures, sparking concerns about increased competition.

The European Commission approved Opdivo (nivolumab) in combination with AVD on 2026-06-01 for the treatment of Hodgkin Lymphoma; importance is Low as single-indication approvals typically result in a 1-3% price impact.

The U.S. FDA accepted a supplemental New Drug Application for Camzyos on 2026-06-01, granting Priority Review; importance is Low as application acceptance is a procedural milestone with minor price impact.

The ex-dividend date for NIKE's quarterly cash dividend of $0.41 per share was June 1, 2026. The dividend was declared on May 4, 2026.

CEO Cristiano Amon keynote at Computex 2026, outlining the company's AI strategy and introducing the 'Dragonfly' brand, scheduled. Estimated > 1% impact due to new brand introduction.

Announced positive Phase 3 SUCCESSOR-2 trial results for mezigdomide on 2026-05-29, showing a 52% reduction in disease progression risk; importance is Low as clinical trial results usually impact price by 1-4%.

Ex-dividend date for a 5% increased quarterly dividend of $0.4725 per share, announced on May 4, 2026.

Announced the appointment of Scott A. Keller as the new general counsel on May 29, 2026, effective July 1, 2026, as part of a planned succession for the current chief legal officer who is expected to retire in 2027.

The FDA granted Breakthrough Therapy Designation for the investigational KRAS G12C inhibitor calderasib (MK-1084) on May 29, 2026.

UPS announced a $50 million investment to enhance logistics for North American manufacturers, including expansion of air freight services to Mexico. Low importance is estimated due to the modest investment size scheduled.

Argus raised its price target on Williams Cos. to $85 from $83 on May 29, 2026, while maintaining a 'Buy' rating, with low impact expected from this minor adjustment, forecasted.

CEO Lauren Hobart sold 20,083 shares for approximately $4.58 million following an option exercise. This was part of broader insider selling totaling $42.5 million over the prior three months with no insider purchases reported.